HILLEVAX, INC.

HLVX13 Dec 2024
Healthcare
$1.97
-0.01 (-0.76%)
Lowest Today
$1.96
Highest Today
$1.99
Today’s Open
$1.97
Prev. Close
$1.98
52 Week High
$20.22
52 Week Low
$1.55
To Invest in HILLEVAX, INC.

HILLEVAX, INC.

Healthcare
HLVX13 Dec 2024
-0.01 (-0.76%)
1M
3M
6M
1Y
5Y
Low
$1.96
Day’s Range
High
$1.98
1.96
52 Week Low
$1.55
52-Week Range
52 Week High
$20.22
1.55
1 Day
-
1 Week
-0.99%
1 month return
+4.46%
3 month return
+8.74%
6 month return
-86.55%
1 Year return
-86.5%
3 Years return
-
5 Years return
-
10 Years return
-
Institutional Holdings
TANG CAPITAL MANAGEMENT LLC
9.88
BlackRock Inc
4.2
Franklin Resources Inc
3.93
Deerfield Management Co
3.78
The Carlyle Group Inc
3.69
Vanguard Group Inc
3.16
Franklin Biotechnology Discv A(acc)USD
2.53

Market Status

Fundamentals
Market Cap
99.11 mln
PB Ratio
0.54
PE Ratio
0
Enterprise Value
-65.22 mln
Total Assets
344.43 mln
Volume

Company Financials

Fund house & investment objective

Company Information
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Organisation
HILLEVAX, INC.
Employees
90
Industry
Biotechnology
CEO
Dr. Robert M. Hershberg M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step